Amwill Health Care Business Update

Amwill Health Care Other Announcement

Amwill Health Care committed ₹3 Crore to Nippon India Credit Opportunities AIF Scheme II. The investment, funded from internal accruals, is drawn down in tranches.

Value

₹3.00 Cr

Amwill Health Care Dividend

Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.

Amwill Health Care H1 FY27 Results: Net Profit ₹3.7 Cr, Down 50.7% YoY

Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.

Key figure

Net profit ₹3.7 Cr · -50.7% YoY

Amwill Health Care Board Meeting Date

Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.

Amwill Health Care Other Announcement

This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.

Amwill Health Care Regulatory Approval

Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.

Kothari Industrial Corporation Business Update

Kothari Industrial intimated plans to relocate its KICKERS showroom from Indore. The destination city, premises and timing remain undecided.

Vishnu Chemicals Business Update

Vishnu Chemicals' Parwada plant in Visakhapatnam resumed full operations on 13 November 2026. The earlier temporary stoppage was for forward integration and new capital projects.

Sharp Chucks And Machines Business Update

SCML entered a PPA with Spark Grid Project B for captive renewable energy, acquiring 26% equity in the SPV. No contract value or capacity is disclosed.

DEE Development Engineers Business Update

DEE Development Engineers reported its October 2026 order book with a closing position of $2,586.43 million. No single new award is announced in this periodic update.

Novelix Pharmaceuticals Business Update

Novelix Pharmaceuticals entered a supply agreement with axabio NV, Belgium, to procure natural astaxanthin. No specific contract value was disclosed.

Edelweiss Financial Services Business Update

Edelweiss released a business update of its subsidiary Zuno General Insurance. The deck covers industry outlook, growth dynamics, approach and aspirations, with no monetary figures.